stockportfolio.pro
Schrödinger, Inc. (SDGR)
Healthcare · Health Information Services · NasdaqGS
Schrödinger, Inc. revenue & earnings — last 7 fiscal years
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $85.54M | $108.09M | $137.93M | $181.00M | $216.70M | $207.54M | $255.87M |
| Gross profit | $49.09M | $63.47M | $65.62M | $101.02M | $140.69M | $132.08M | $142.61M |
| Net income | $-24.57M | $-24.46M | $-100.39M | $-149.20M | $40.72M | $-187.12M | $-103.27M |
| Net margin | -28.7% | -22.6% | -72.8% | -82.4% | 18.8% | -90.2% | -40.4% |
Source: Schrödinger, Inc. SEC filings (10-K).
Explore 7 years of Schrödinger, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track SDGR in your portfolio →
About Schrödinger, Inc.
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Schrödinger, Inc. — frequently asked questions
What is Schrödinger, Inc.'s revenue?
Schrödinger, Inc. (SDGR) reported revenue of $255.87M for fiscal year 2025, up 23.3% from the prior year, according to its SEC filings.
Is Schrödinger, Inc. profitable?
No — SDGR reported a net loss of $-103.27M in fiscal 2025.
What is SDGR's P/E ratio?
Schrödinger, Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is Schrödinger, Inc. growing?
SDGR's revenue grew at roughly 18.8% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
Where does this data come from?
All figures are computed from Schrödinger, Inc.'s official SEC filings (10-K and 10-Q), covering 7 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.